Intractable Epilepsy: Relapsing, Remitting, or Progressive?

Author：  

Publisher： Blackwell Publishing

ISSN： 1535-7597

Source： Epilepsy Currents, Vol.10, Iss.6, 2010-11, pp. : 146-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon- -1b: A Review of its Use in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By McCormack P.L.   Scott L.J.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 521-546

Adis International

Access to resources Recommend Favorite

Novel vaccine show promise for relapsing-remitting MS

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo   Hartung Hans-Peter   Kurukulasuriya Nuwan C   Greenberg Steven J   Scaramozza Matthew  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio   Ruggieri Serena  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis

By Muir Victoria J.   Plosker Greg L.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite